Zhejiang Xingyue Biotechnology Co., Ltd

Zhejiang Xingyue Biotechnology Co., Ltd. was established in 2010, focusing on the fields of sports medicine and regenerative medicine. The company specializes in the research, development, production, and sales of medical devices using silk fibroin as raw material, and assists hospitals in the clinical application of tissue regenerative medicine technology. At the same time, it expands the application research of silk fibroin in medical aesthetics, skincare, food, and other fields.

Company Profile

Zhejiang Xingyue Biotechnology Co., Ltd. was established in 2010. It is a national high-tech enterprise jointly created by a team of overseas returnee PhDs and China Xingyue Group. Located in Hangzhou Future Science and Technology City (one of the four major future science and technology cities in China), it has a 5000 square meter GMP purification workshop and laboratory.

The company uses silk as the main material and has established a large-scale production line for medical silk materials. It has applied for 38 patents related to biomaterials, including 20 authorized invention patents, including 1 international patent; Apply for registration of 5 medical device master documents; Participated in drafting 2 industry standards. The listed products independently developed by the company mainly include silk fibroin membrane dressing, disposable ribbon device, silk fibroin hydrogel dressing, non absorbable surgical suture, silk fibroin gel dressing, silk fibroin hernia repair patch, etc.

We have established multiple innovative platforms, including the Zhejiang Provincial Key Enterprise Research Institute for Medical Materials and Tissue Engineering, the Zhejiang Provincial Key Laboratory for Tissue Engineering and Regenerative Medicine Technology, and the Hangzhou Academician Expert Workstation. We have also established close industry university research cooperation relationships with many universities and institutions, such as Zhejiang University, the Shanghai Institute of Ceramics of the Chinese Academy of Sciences, Jiangnan University, and Zhejiang University of Technology. In 2012 and 2015, we have continuously undertaken national "Twelfth Five Year Plan" 863 Program projects.

The company has achieved the first breakthrough in the medical field with medical silk materials: silk fibroin class III medical device products (silk fibroin membrane dressings), silk fibroin class III implantable medical devices that have officially entered clinical trials (silk fibroin hernia repair patches), silk fibroin tissue repair material master document (M2021005-000), and silk fibroin raw material industry standard "Tissue Engineering Medical Device Silk fibroin".

Corporate Milestones

In 2010, Zhejiang Xingyue Biotechnology Co., Ltd. was established.

In 2011, the Hangzhou Academician Expert Workstation was established as recognized by the Hangzhou Academician Expert Workstation Construction Coordination Group.

In 2012, with the support of the Zhejiang Provincial People's Government, the Zhejiang Medical Materials and Tissue Engineering Key Enterprise Research Institute was established.

In 2013, the medical tissue patch independently developed by the company obtained the EU CE registration certificate.

In 2014, undertook the research and development of the "Organizational Engineering New Materials Project", a major science and technology special project in Zhejiang Province.

In 2015, undertook the national "Twelfth Five Year Plan" 863 Program project.

In 2016, the research and development project "Research and Application of Bioactive Artificial Bone Related Technologies" won the second prize of Weihai Science and Technology.

In 2017, it was recognized by the Science and Technology Bureau of Yuhang District, Hangzhou and obtained the certificate of "Yuhang District Science and Technology Enterprise R&D Center".

In 2018, "silk fibroin sterile wound protection film" entered the "Medical Device Priority Approval Procedure" of the National Medical Products Administration.

In 2019, the company's research and development project "In situ Repair and Regeneration Technology of Osteocartilage" won the first prize of the Ministry of Education's Science and Technology Invention Award.

In February 2020, the Chinese pharmaceutical industry standard YY/T1680-2020 "In vivo osteogenic induction performance evaluation of demineralized bone materials for allogeneic repair materials" was released and implemented in 2021.

In June of the same year, the "silk fibroin membrane dressing" successfully obtained the product registration certificate (National Medical Device Approval No. 20203140593) and was launched on the market.

In May 2021, the main document of "Silk fibroin tissue repair material (medical tissue patch)" was registered and filed with the National Medical Products Administration as a medical device main document.

In June of the same year, a wholly-owned subsidiary, Siraimei Biotechnology (Zhejiang) Co., Ltd., was established.

In October of the same year, the "Disposable Belt Retractor" was certified and launched.

In 2022, the "silk fibroin hydrogel dressing" will be licensed and listed. In December of the same year, the industry standard for tissue engineering medical device silk fibroin was approved.

In 2023, the medical device products "non absorbable surgical suture" and "silk fibroin gel dressing" independently developed by the company were approved for listing.

In March 2024, the silk material hernia repair product "silk fibroin hernia repair patch", which was clinically validated by multiple centers, was successfully approved for market launch.

Corporate Honors

In 2013, it was awarded the "Hangzhou High tech Enterprise" certificate by the Hangzhou Science and Technology Commission.

2014

In June, awarded the honorary title of "Zhejiang Province Key Innovation Team".

In September, it was recognized as a national high-tech enterprise.

In December, obtained the certificate of "Hangzhou Enterprise High tech Research and Development Center" issued by the Hangzhou Science and Technology Commission.

2015

In February, the R&D project "Research on the Treatment of Terminal Diseases with Different Intervention Factors" won the first prize of Weihai Science and Technology Award.

In November, it was approved to establish a "Postdoctoral Research Workstation".

In 2017, it was awarded the certificate of "Hangzhou Yuhang District Science and Technology Enterprise R&D Center" by the Yuhang District Science and Technology Bureau of Hangzhou City.

2019

In May, the research and development project "Sports System Tissue Engineering and Repair Regeneration Technology" won the second prize of Science and Technology from the Chinese Society for Biomaterials.

In November, the research and development project "Key Technologies and Clinical Applications of Integrated Traditional Chinese and Western Medicine for the Prevention and Treatment of Delayed Healing and Non Healing Fractures" won the second prize of Shandong Province Science and Technology Progress Award.

In March 2024, awarded the "Innovation Star" of the Biomedical and Medical Device Industry in Yuhang District for the year 2023.

Corporate Culture

Corporate Positioning

Integrating Chinese civilization with regenerative technology to benefit human health and economic development

Corporate Mission

Let silk enter the medical world, let medical silk enter the world

Corporate Vision

Technology cares for health, technology radiates beauty

Corporate Values

High level, distinctive, and in need

Subsidiary brands

SILKFACTOR, a brand specializing in regenerated silk fibroin protein. On March 12, 2024, the global launch event of the Silky Beauty brand was launched in Yongkang, Zhejiang.

SILKINAIS, a wholly-owned subsidiary of Xingyue Biotechnology (Zhejiang) Co., Ltd., holds the brand and focuses on the effective skin care brand of sensitive muscle anti-aging.

Nature of Business

General projects: technical services, technology development, technology consulting, technology exchange, technology transfer, technology promotion; Promotion services for new material technology; Research and development of bio based material technology; Research and development of biochemical product technology; Production of Class I medical devices; Manufacturing of biobased materials; Manufacturing of basic chemical raw materials (excluding the manufacturing of licensed chemicals such as hazardous chemicals); Manufacturing of daily chemical products; Manufacturing of specialized equipment for daily chemical industry; Sales of Class I medical devices; Sales of Class II medical devices; Sales of biobased materials; Wholesale of cosmetics; Retail of cosmetics; Sales of daily chemical products; Sales of chemical products (excluding licensed chemical products); Disinfectant sales (excluding hazardous chemicals); Import and export of goods; Technology import and export; Engineering and technical research and experimental development; Medical research and experimental development; Non residential real estate leasing; Property management (except for projects that require approval according to law, independently carry out business activities based on the business license in accordance with the law). Licensed project: Production of Class II medical devices; Production of Class III medical devices; Pharmaceutical production Commissioned production of drugs; Cosmetics production; Production of hygiene products and disposable medical supplies; The third type of medical device operation (projects that require approval by law can only be carried out after approval by relevant departments, and specific business projects are subject to the approval results).